A Study on Cardiopulmonary Exercise Tolerance Standards for Healthy Chinese Population

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAffiliated Hospital of Changchun University of Chinese Medicine

About this trial

This project intends to conduct a large-sample, prospective, multicenter clinical cohort study in healthy populations. By utilizing a digital cardiopulmonary rehabilitation clinical data research platform, The investigators aim to achieve automated, standardized, and uniform collection, analysis, and AI modeling of large-scale cardiopulmonary exercise testing (CPET) data. The ultimate goals are:

To establish reference standards for cardiopulmonary exercise capacity in the Chinese healthy population.

To develop machine learning-based predictive models for key CPET variables (e.g., peak VO₂) tailored to Chinese demographics.

To compare performance differences between domestically produced and imported CPET devices.

Eligibility criteria

Qualifiers

Detailed medical history taken, with no symptoms of discomfort reported

Good physical condition, with no history of severe chronic diseases

No history of long - term medication use

Willing to undergo cardiopulmonary exercise testing, with no ST - T segment changes observed during the test

Disqualifiers

Pre - test resting blood pressure ≥160/100 mmHg (1 mmHg=0.133 kPa)

Chronic cardiovascular diseases, such as heart failure, coronary atherosclerotic heart disease, hypertension, congenital heart disease, cardiomyopathy, and severe arrhythmias

Respiratory diseases, such as chronic obstructive pulmonary disease, asthma, pulmonary artery hypertension, bronchiectasis, and respiratory failure

Digestive system diseases, such as peptic ulcer, gastrointestinal bleeding, hepatitis, liver cirrhosis, ulcerative colitis, Crohn's disease, chronic pancreatitis, and chronic cholecystitis

Trial design

Treatments tested in this trial

  • cardiopulmonary exercise testing (CPET)

Treatment groups

4,620 Participants
are divided into 1 treatment group